Описание

Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.

Figure 21

Diagram

Source Paper

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease.

Pharmaceuticals (Basel, Switzerland) (2023)

PMID: 37631065

DOI: 10.3390/ph16081150

Cite This Figure

![Figure 21: Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.]()

> Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37631065](https://pubmed.ncbi.nlm.nih.gov/37631065/)

<figure>
  <img src="" alt="Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation." />
  <figcaption>Figure 21. Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.<br>  Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37631065/">37631065</a></figcaption>
</figure>

Связанные доказательства

Curcumin для Ulcerative Colitis (UC)

Оценка B · 5 исследований

N-Acetyl Cysteine (NAC) для Inflammatory Bowel Disease (IBD) — General

Оценка D · 1 исследований